Permanent 125iodine implants for recurrent malignant gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 5, 1999, Pages 977-982

  Gaspar, Laurie E ^a   Zamorano, Lucia J ^b   Shamsa, Falah ^a   Fontanesi, J ^a   Ezzell, Gary E ^a   Yakar, Daniel A ^c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Brachytherapy; Gliomas

Indexed keywords

IODINE 125; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; GLIOBLASTOMA; HISTOLOGY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION NECROSIS; RECURRENT CANCER; TREATMENT OUTCOME; TUMOR GROWTH; BRAIN TUMOR; FEMALE; FOLLOW UP; GLIOMA; MALE; MIDDLE AGED; MORTALITY; SURVIVAL; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 0032587614     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00494-5     Document Type: Article

References (30)

1. Burger P.C., Dubois P.J., Schold C., Smith K.R., Odom G.L., Crafts D.C., Giangaspero F. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg. 58:1983;159-169.
2. Chocair A.K., Levin V.A., Gutin P.H., Davis R.L., Silver P., Edwards M.S.B., Wilson C.B. Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg. 65:1986;654-658.
3. Gaspar L.E., Fisher B.J., Macdonald D.R., LeBer D.V., Halperin E.C., Schold S.C., Cairncross J.G. Supratentorial malignant glioma patterns of recurrence and implications for external beam local treatment . Int J Radiat Oncol Biol Phys. 24:1992;55-57.
4. Halperin E.C., Bentel G., Heinz E.R., Burger P.C. Radiation therapy treatment planning in supratentorial glioblastoma multiforme an analysis based on post mortem topographic anatomy with CT correlations . Int J Radiat Oncol Biol Phys. 17:1989;1347-1350.
5. Mornex F., Nayel H., Taillandier L. Radiation therapy for malignant astrocytomas in adults. Radiother Oncol. 27:1993;181-191.
6. Massey V., Wallner K.E. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys. 18:1990;395-398.
7. Florell R.C., Macdonald D.R., Irish W.D., Berstein M., Leibel S.A., Gutin P.H., Cairncross J.G. Selection bias, survival, and brachytherapy for glioma. J Neurosurg. 76:1992;179-183.
8. Prados M.D., Gutin P.H., Phillips T.L., Wara W.M., Sneed P.K., Larson D.A., Lamb S.A., Ham B., Malec M.K., Wilson C.B. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas the UCSF experience . Int J Radiat Oncol Biol Phys. 24:(4):1992;593-597.
9. Scharfen C.O., Sneed P.K., Wara W.M., Larson D.A., Phillips T.L., Prados M.D., Weaver K.A., Malec M., Acord P., Lamborn K.R., Lamb S.A., Ham B., Gutin P.H. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys. 24:1992;583-591.
10. Fernandez P.M., Zamorano L., Yakar D., Gaspar L., Warmelink C. Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery. 36:(3):1995;467-473.
11. Gaspar L., Zamorano L., Garcia L., Shamsa F., Warmelink C., Yakar D. Malignant gliomas permanent iodine-125 implants . Int J Radiat Oncol Biol Phys. 30:(Suppl.1):1994;295.
12. Yakar D., Zamorano L., Dujovny M., Sheehan M., Kim J.H. Interstitial I-125 irradiation for malignant brain tumors advantage of permanent implant (PI) over temporary implants (TI) . Int J Radiat Oncol Biol Phys. 24:(33):1992;143.
13. Zamorano L., Yakar D., Dujovny M., Sheenan M., Kim J. Permanent iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg. 59:1992;183-192.
14. Warmelink C., Edmundson G.K., Martinez A. The use of lead rubber shielding for patients undergoing temporary I-125 implants. Endocuriether Hypertherm Oncol. 4:1987;86.
15. 125I brachytherapy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys. 35:1996;541-547.
16. Mundinger F., Birg W., Weigel K. Stereotactic treatment of brain lesions. Appl Neurophysiol. 43:1980;198-204.
17. Hoshino T. The cell kinetics of gliomas its prognostic value and therapeutic implications . Neuro-oncol. 1:1979;105-112.
18. Malise E.P., Fertil B., Chavaudra N., Guichard M. Distribution of radiation sensitivities for human tumor cells of specific histological types comparison of in vitro and in vivo data . Int J Radiat Oncol Biol Phys. 12:1986;617-624.
19. Bernstein M., Laperriere N., Leung P., McKenzie S. Interstitial brachytherapy for malignant brain tumors preliminary results . Neurosurgery. 26:(1):1990;371-379.
20. Eddy M.S., Selker R.G., Anderson L.L. On a method of dosimetry planning and implantation of 125-I for interstitial irradiation of malignant gliomas. J Neuro-Oncol. 4:1986;131-139.
21. Saw C.B., Suntharalingam N., Ayyangar K.M., Tupchong L. Dosimetric considerations of stereotactic brain implants. Int J Radiat Oncol Biol Phys. 17:1989;887-891.
22. Arbit E., Shapiro J.R., Fiola M., Malkin M., Galicich J. The significance of morphologically viable glioma cells found at the time of operation after interstitial brachytherapy. Neurosurgery. 32:(1):1993;105-110.
23. Daumas-Duport C., Blond S., Vedrenne C.I., Szikla G. Radiolesion versus recurrence; bioptic data in 39 gliomas after interstitial, or combined interstitial and external radiation treatment. Acta Neurochir. 33:(Suppl):1984;291-299.
24. Orton C.G. Recent developments in time-dose modeling. Australas Phys Engin Sci Med. 14:(2):1991;57-64.
25. Porrazzo M.S., Hilaris B.S., Moorthy C.R., Tchelebi A.E., Mastoras C.A., Shih L.L., Stabile L., Salvaras N. Permanent interstitial implantation using palladium-103 The New York Medical College preliminary experience . Int J Radiat Oncol Biol Phys. 23:1992;1033-1036.
26. Finger P.T., Lu D., Buffa A., DeBlasio D.S., Bosworth J.L. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. Int J Radiol Oncol Biol Phys. 27:1993;849-854.
27. Warmelink C., Gaspar L., Ezzell G., Zamorano L., Wierzbicki J. The dosimetric limitations of palladium-103 in permanent implants of brain tumors. Proc Am Endocuriether Soc. 99:1993;4-31.
28. Wood J.R., Green S.B., Shapiro W.R. The prognostic importance of tumor size in malignant gliomas a computed tomographic scan study by the Brain Tumor Cooperative Group . J Clin Oncol. 6:(2):1988;338-343.
29. Lucas G.L., Luxton G., Cohen D., Petrovich Z., Langholz B., Apuzzo M.L.J., Sapozink M.D. Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors. Int J Radiat Oncol Biol Phys. 21:1991;715-721.
30. Lunsford L.D., Deutsch M., Yoder V. Stereotactic interstitial brachytherapy-current concepts and concerns in twenty patients. Appl Neurophysiol. 48:1985;117-120.